The Center for Global Health Policy’s “Science Speaks” blog highlights a recently published blog post on PEPFAR, “written by amfAR Public Policy Director Chris Collins and Health GAP Senior Policy Analyst Matthew Kavanagh, [which] warns that with current funding levels and proposed continued funding cuts, the pace of treatment enrollment will stall, and the numbers of new people receiving treatment through PEPFAR will plunge. With the Obama administration making final budget decisions this week for fiscal year 2015, to be released to Congress on March 4th, the post makes the case for returning to 2011 funding levels for PEPFAR for more rapid scale-up of HIV treatment…” (Aziz, 1/28).